CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$4.19 USD
+0.12 (2.95%)
Updated May 8, 2024 04:00 PM ET
After-Market: $2.78 -1.41 (-33.65%) 7:54 PM ET
5-Strong Sell of 5 5
F Value C Growth F Momentum D VGM
Brokerage Reports
CytomX Therapeutics, Inc. [CTMX]
Reports for Purchase
Showing records 141 - 149 ( 149 total )
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Platform Continues to Broaden Ahead of Data- Rich 2018
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
CTMX Adds AMGN to the Partner List with Bispecific Collaboration
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating coverage with an OUTPERFORM and $26 price target
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R